Výsledky vyhledávání - "Colden Johanson"

Abstract P1-11-19: A real-world evidence study of treatment patterns in patients with HER2-positive metastatic breast cancer who have received at least 2-lines of therapy

Autor: Della Varghese, Giovanna I. Cruz, Colden Johanson, Liz Toland, Miguel Miranda, Eleanor C. Faherty, David Harland, Henry G. Kaplan

Publikováno v: Cancer Research. 83:P1-11

Background. Standard-of-care treatment for HER2-positive metastatic breast cancer (HER2+ mBC) patients has traditionally included targeted therapies such as trastuzumab and/or pertuzumab in first line (1L) and ado-trastuzumab emtansine (T-DM1) in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::38d6a9cefa9b1a1348b00ad7ea93d476
https://doi.org/10.1158/1538-7445.sabcs22-p1-11-19

Zobrazit plný text záznamu

Epidemiology of interstitial lung disease in patients with metastatic breast cancer at baseline and after treatment with HER2-directed therapy: a real-world data analysis

Autor: Jeanna Wallenta Law, Alicyn Campbell, Colin Weller, Colden Johanson, Ronda Broome, Elisabeth Piault, Monika Izano, Andrew Schrag, Mary Tran, Thomas D. Brown, Henry G. Kaplan

Publikováno v: Breast Cancer Research and Treatment. 196:603-611

Purpose Using real-world data, interstitial lung disease (ILD) prevalence before and after HER2-directed therapy was estimated. Potential ILD risk factors in patients receiving HER2-directed therapy for metastatic breast cancer (mBC) were evaluated.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1551e13d8609077a1678f529c429f51
https://doi.org/10.1007/s10549-022-06738-6

Zobrazit plný text záznamu

Abstract P2-09-05: Germline BRCA1/2 mutation testing in human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC): A real-world study in the Syapse Learning Health Network (LHN)

Autor: Alexander Niyazov, Monika Izano, Colden Johanson, Sheetal Walters, Anna Berry, Bhakti Arondekar, A. Douglas Laird, Lillian Shahied Arruda, Henry Kaplan

Publikováno v: Cancer Research. 82:P2-09

Background: Germline (g)BRCA1/2 mutations represent approximately 5% of metastatic breast cancer. Poly ADP-ribose polymerase inhibitors (PARPi) have shown improved clinical outcomes, a manageable toxicity profile, and favorable patient (pt)-reported

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f90e15db9d6114ef7f99456bf194654
https://doi.org/10.1158/1538-7445.sabcs21-p2-09-05

Zobrazit plný text záznamu

Abstract 4089: Time to treatment discontinuation and time to next treatment as proxies of real-world progression-free survival in breast cancer patients

Autor: Monika A. Izano, Mahder Teka, Colden Johanson, Jeanna Wallenta Law, Ronda Broome, Daniele Morgan, Amy Stone, Mary Tran, Thomas D. Brown, Chenan Zhang

Publikováno v: Cancer Research. 82:4089-4089

Background: There is no standardized real-world proxy for progression-free survival (PFS), although it is a key treatment response metric in clinical trials. Real-world PFS (rwPFS) has been curated from clinician-documented progression in unstructure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b773aa2de3b41bf2d71b8d1064156794
https://doi.org/10.1158/1538-7445.am2022-4089

Zobrazit plný text záznamu

Machine learning application to find patients with lower-risk myelodysplastic syndrome from real-world data

Autor: Colden Johanson, Hu T. Huang, Danny Idryo, Ronda Broome, Matthew J. Rioth, Rayna K. Matsuno

Publikováno v: Journal of Clinical Oncology. 40:1555-1555

1555 Background: It is a challenge to identify patients with myelodysplastic syndrome (MDS) using structured data from electronic health records (EHRs). Current claims-based algorithms incorporating diagnosis codes, clinical labs, and procedures have

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ee2903d54a2989e5224ef05c1d325c0
https://doi.org/10.1200/jco.2022.40.16_suppl.1555

Zobrazit plný text záznamu

The impact of overdiagnosis on the selection of efficient lung cancer screening strategies

Autor: Harry J. de Koning, Colden Johanson, Sylvia K. Plevritis, Rafael Meza, Saadet Ayca Erdogan, Chung Yin Kong, Pamela M. McMahon, Jihyoun Jeon, Summer S. Han, William D. Hazelton, Vidit Munshi, Kevin ten Haaf, Eric J. Feuer

Publikováno v: International Journal of Cancer. 140:2436-2443

The U.S. Preventive Services Task Force (USPSTF) recently updated their national lung screening guidelines and recommended low-dose computed tomography (LDCT) for lung cancer (LC) screening through age 80. However, the risk of overdiagnosis among old

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6352bdf877bf7d6cd6eaad6565a1c9cb
https://doi.org/10.1002/ijc.30602

Zobrazit plný text záznamu

Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients

Autor: Colden Johanson, Milton C. Weinstein, Konstantinos P. Economopoulos, Stephen Sy, Martin Reincke, Thomas A. Gaziano, Heike E. Kunzel, Carrie C. Lubitz, G. Scott Gazelle

Publikováno v: Circulation: Cardiovascular Quality and Outcomes. 8:621-630

Background— Primary aldosteronism (PA) is a common and underdiagnosed disease with significant morbidity potentially cured by surgery. We aim to assess if the long-term cardiovascular benefits of identifying and treating surgically correctable PA o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a489bfb004eea8329f843e15979a0b39
https://doi.org/10.1161/circoutcomes.115.002002

Zobrazit plný text záznamu

Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis

Autor: Pamela M. McMahon, Angela C. Tramontano, Chung Yin Kong, Michael E. Gilmore, Vidit Munshi, Kathryn P. Lowry, Colden Johanson, G. Scott Gazelle, Sung Eun Choi

Publikováno v: Cancer. 121:1556-1562

Background Lung cancer screening with annual chest CT is recommended for current and former smokers with ≥30+ pack-year smoking history. Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of developing lung cancer and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c853f64adba365df38c8517dff842f2
https://doi.org/10.1002/cncr.29225

Zobrazit plný text záznamu

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force

Autor: Iris Lansdorp-Vogelaar, Steffie K. Naber, Sara E. Fischer, Colden Johanson, Carolyn M. Rutter, Chester Pabiniak, V. Paul Doria-Rose, Karen M. Kuntz, Ann G. Zauber, Amy B. Knudsen

Publikováno v: JAMA-Journal of the American Medical Association, 315(23), 2595-2609. American Medical Association

Importance The US Preventive Services Task Force (USPSTF) is updating its 2008 colorectal cancer (CRC) screening recommendations. Objective To inform the USPSTF by modeling the benefits, burden, and harms of CRC screening strategies; estimating the o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5850eb77bc6323374ef6cde5ecd9c65
https://pure.eur.nl/en/publications/bf27d62a-b715-4b25-b8c6-8884bb951b9d

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání